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Introduction
Chromatin structure is controlled by the level of
core histone acetylation, which is determined by the
balance between histone acetyl transferase (HAT) and
histone deacetylase (HDAC) activity [19]. Changes in
chromatin acetylation are a key event in transcription-
al regulation of genes. Hyperacetylation of histones is
associated with transcriptional activity, whereas his-
tone hypoacetylation represses gene expression [7,
19]. Thus, regulation of gene expression includes tran-
scription factors, which recruit HATs and HDACs to
acetylate and deacetylate histones and modify chro-
matin structure [7, 19].
CD4 is a cell surface antigen, its presence is essen-
tial for T cell stimulation and function [8]. The T cells
stimulation is triggered by direct interaction of the T
cell receptor /CD3 complex (CD3/TCR) with an anti-
gen bound to the major histocompatibility complex
(MHC) on antigen presenting cells (APC) such as den-
dritic cells, B lymphocytes and macrophages [5, 8, 10,
11, 13]. During CD4+ T cells stimulation, CD4 binds to
a monomorphic region of the MHC class II molecule
and increases the avidity of T cell for APC. Interaction
of the CD4 with the MHC II molecule enables lck tyro-
sine kinase to phosphorylate the CD3zeta chain of the
CD3/TCR complex. Phosphorylation of CD3zeta
begins cascade of events leading to lymphocyte activa-
tion and biosynthesis of cytokines and costimulatory/
adhesion molecules that can initiate humoral or cyto-
toxic response [2]. CD4+ T lymphocytes are considered
to play a key role in loss of self-tolerance and CD4 anti-
gen can be associated with the development of certain
autoimmune diseases [4, 15]. Modulation of CD4
expression may decrease activation threshold and can
be the target for immunotherapy [2].
Trichostatin A (TSA) is a reversible HDAC
inhibitor that deregulates gene expression and affects
cell proliferation and differentiation [14, 16]. High con-
centrations of TSA cause apoptosis of various cell types
[12, 14, 16, 21]. It has been recently reported that TSA
at lower concentrations may act as an immunomodula-
tor, altering expression of some genes encoding pro-
teins involved in immune response, such as cytokines,
costimulatory/adhesion molecules and MHC class II
antigens [14, 16]. Thus, this drug might be useful in the
treatment of certain autoimmune disorders.
We previously reported that TSA significantly low-
ered transcription level of Elf-1 in Jurkat T leukemia
cells [13]. Elf-1 is a member of the E-26 specific (Ets)
FOLIA HISTOCHEMICA
ET CYTOBIOLOGICA
Vol. 44, No. 4, 2006
pp. 259-262
Effect of Trichostatin A on CD4 surface density 
in peripheral blood T cells
Anna Koz³owska and Pawe³ P. Jagodziñski
Department of Biochemistry and Molecular Biology, University of Medical Sciences, Poznañ, Poland
Abstract: Acetylation level of chromatin histones is maintained by histone acetylases (HATs) and deacetylases (HDACs)
and correlates with transcriptional activity of genes. Trichostatin A (TSA) is HDAC inhibitor that causes various effects in
cells, including immunomodulation. The CD4 antigen is a key coreceptor involved in activation of T helper cells. Using
quantitative real-time PCR (RQ-PCR) and flow cytometry techniques, we estimated CD4 transcript level and density of
CD4 antigen on the surface of TSA-treated stimulated and unstimulated peripheral T cells. We observed a dose dependent
decrease in CD4 mRNA level and antigen density on surface of TSA-treated stimulated T cells. However, we did not observe
any significant TSA effect on CD4 mRNA and protein expression in unstimulated T cells. Our data suggest that TSA may
induce biosynthesis of factors responsible for negative regulation of CD4 antigen expression in stimulated T cells. Our
investigation may support previous observation that this drug has immunosuppresive effect on primary T cells and may be
useful in treatment of certain autoimmune disorders.
Key words: Trichostatin A - Histone deacetylases - CD4 antigen - Flow cytometry
Correspondence: A. Koz³owska, Dept. Biochemistry and Molecular
Biology, University of Medical Sciences, Œwiêcickiego 6, 
60-781 Poznañ, Poland; e-mail: kozlowa@am.poznan.pl
family transcription factors that is also implicated in
the transcriptional regulation of genes such as CD3-ζ,
IL-2, IL-2R, α-chain, granulocyte-macrophage
colony-stimulating factor (GM-CSF), blk, lck, and lyn
kinases [18, 20]. Elf-1 binds to the CD4 promoter and
is critical for its function [18, 20]. 
Employing quantitative real-time PCR (RQ-PCR)
and flow cytometry we evaluated the effect of TSA on
CD4 mRNA level and surface density in human stim-
ulated and unstimulated peripheral T lymphocytes. 
Materials and methods
Reagents and cell culture. The peripheral blood samples were
collected from volunteers and were used to obtain peripheral blood
mononuclear cells (PBMCs). The PMBCs were isolated by cen-
trifugation over Ficoll-Hypaque (d=1.077 g/cm3) [6]. Phyto-
haemagglutinin (PHA) treatment, in contrast to CD28/CD3
crosslinking, stimulates naive T cells to produce a wide range of
cytokines that depend on expression of AP1 and NFkappaB tran-
scription factors [17]. Additionally, in PHA stimulated T cells no
significant decrease in cell surface CD4 density is observed [1], and
after 4 h stimulation most cells exhibit CD69 expression and high
rate of proliferation. Freshly isolated PBMCs were incubated for 4
h either without or in the presence of 10 μg/ml PHA. The cells were
then washed and cultured for additional 72 h in the RPMI 1640
medium (GibcoBRL, Grand Island, NY, USA) in a mixture of 5%
CO2 and 95% air at 37°C. The culture medium was supplemented
with 10% fetal bovine serum (FBS), 2 mM L-glutamine, peni-
cillin/streptomycin mix (Sigma Chemical, St Louis, MO, USA) and
recombinant interleukin-2 (rIL-2, 40 U/ml, R&D Systems Inc, Min-
neapolis, MI, USA). Stimulated and unstimulated PBMCs were
suspended at a density of 0.5×106 cells/ml in RPMI medium and 1
ml cell suspensions were placed in 24-well polystyrene plates.
Plates were then incubated for 24 h either without or in the presence
of TSA at concentrations of 3, 30 and 300 nM [9].
RQ-PCR analysis of CD4 transcript level in PBMCs. Total
RNA was isolated from PBMCs according to Chomczyñski and
Sacchi method (1985) [3]. RNA integrity was confirmed by dena-
turing agarose gel electrophoresis, and the concentration was
quantified by measuring the optical density (OD) at 260 nm.
RNA samples were treated with DNase I, and reverse-transcribed
into cDNA using oligo-dT primers. RQ-PCR was conducted in a
Light Cycler real-time PCR detection system (Roche Diagnostics
GmbH, Mannheim, Germany) using SYBR® Green I as detection
dye and target cDNA was quantified using relative quantification
method. The quantity of CD4 transcript in each sample was stan-
dardized by polymerase II cDNA levels. The CD4 cDNA ampli-
con 205 bp was amplified employing pair of primers: (5'
CTGGCTCTGGAAACCTCAC 3') (forward, nt 1026-1045) and (5'
ACCCACACCGCCTTCTCC 3') (reverse, nt 1213-1231). Poly-
merase II cDNA 163 bp amplicon was also amplified using primer
pairs: (5' GCAAATTCACCAAGAGAGAC 3') (forward, nt 3615-
3635) and (5 ATGTGACCAGGTATGATGAG 3') (reverse, nt
3758-3778). The CD4 and polymerase II cDNA primers were respec-
tively designed based on sequences ENST00000011653 and
ENST00000322644 located in Ensembl Genome Browser
(www.ensembl.org). For amplification, 2 μl of cDNA was added to
18 μl of PCR mix containing HotStartTaq DNA polymerase, reaction
buffer, dNTP mix, SYBR Green I dye, 2.5 mM MgCl2 (Roche Diag-
nostics GmbH, Mannheim, Germany) and primers. One RNA sample
of each preparation was processed without RT-reaction to provide a
negative control in subsequent PCR reactions. RQ-PCR results are
expressed as a percentage of their respective controls (Fig. 1).
Flow cytometry. For direct flow cytometric analysis of the CD4
density on the T cell surface, 1×105 cells were harvested and
stained with Tritest™ (Becton-Dickinson, San Jose, CA, USA)
Fluorescein isothiocyanate (FITC)/ Peridinin chlorophyll protein
(PerCP) conjugated with anti-CD4/CD3 monoclonal antibodies, or
negative isotype controls. The cells were immediately analyzed on
FACSCanto Flow Cytometer (Becton-Dickinson, San Jose, CA,
USA). The decrease in CD4 molecule density on cell surface was
calculated according to 100-(MFx-MFo)/(MFc-MFo) × 100, where
MF is the mean fluorescence intensity of cell stained with FITC-
conjugated anti CD4, in the presence of (MFx) or absence (MFc)
of TSA. Control represents fluorescence of cell stained with an
appropriate isotope antibody (MFo).
Results and discussion
There is an increasing evidence that TSA has
immunomodulatory potential [14, 16]. TSA represses
expression of costimulatory and adhesion molecules
including CD11c, CD69, CD28, CD40 and CD40L [16].
However, TSA may also up-regulate expression of CD2,
CD6, CD82 antigens as well as transforming growth fac-
tor β1 (TGFβ1), CX3C chemokine receptor type 1 and
other proteins involved in immune response [16].
It has been recently reported that TSA reduces sta-
bility and therefore mRNA level of several genes [19].
Our investigation has revealed that TSA causes a dose-
dependent decrease in CD4 mRNA in stimulated
PBMCs. Reduction in transcript level achieved 58%,
72% and 76% of their respective controls at TSA con-
centration of 3, 30 and 300 nM, respectively (Fig. 1).
At the concentrations 3 and 30 nM, no apoptotic death
was observed (data not shown). This confirms that
CD4 mRNA decrease is due to HDAC inhibition,
rather than to cytotoxic effect of TSA. However, TSA
did not change mRNA level in unstimulated T cells
(results not shown).
In order to examine whether low mRNA level leads
to decrease in CD4 protein, we determined CD4 den-
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Fig. 1. TSA down-regulates CD4 mRNA in stimulated PBMCs.
Stimulated PBMCs were incubated either without or in the pres-
ence of TSA concentration of 3, 30 and 300 nM. RQ-PCR analy-
sis results are expressed as a percentage of their respective con-
trols. The results were standardized by Polymerase II transcript
level. Each sample was determined in triplicate and results repre-
sent means ± SE from three experiments
sity on cell surface. We observed a dose dependent
decrease in CD4 density on surface of stimulated T
cells. The decrease in CD4 surface density achieved
8%, 40% and 41% in TSA concentration of 3, 30 and
300 nM, respectively (Fig. 2). However, we did not
observe any significant TSA effect on CD4 density on
surface of unstimulated T cells (data not shown). 
We previously reported that TSA significantly low-
ered level of transcription of Elf-1 in Jurkat T leukemia
cells [13]. Negative effect of TSA on Elf-1 expression
may partially explain decrease in CD4 mRNA and den-
sity of CD4 protein on surface of T cells.
The differences between effects of TSA on CD4
density on cell surface may result from different his-
tone acetylation level in stimulated and unstimulated T
cells [7, 19]. Stimulated T cells contain high number of
acetylated histones in chromatin structure that makes
DNA template available for transcription complex [7,
19]. However, the final effect of chromatin hyper-
acetylation on transcription of particular gene has to be
determined experimentally. 
TSA is now being considered to be promising anti-
cancer drug [16, 21]. Our findings suggest that TSA at
low concentration may also have implications in ther-
apy of autoimmune disease, in which exaggerated
CD4 mediated response is observed. The further
detailed investigation of TSA effect on expression of
other genes coding proteins involved in immune
response may provide valuable explanation of mecha-
nism of T cell suppression.
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